Iron chelation with oral deferiprone in patients with thalassemia

被引：0
|
作者：
Nathan, DG [1 ]
Weatherall, DJ
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Oxford, Oxford OX3 9DS, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 339卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1711 / 1712
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Combined Oral Chelation with Deferiprone and Deferasirox on Iron Overload in Transfusion Dependent Children with Thalassemia – A Prospective Observational Study
    Rajeswari Rethinaswamy DivakarJose
    C. G. Delhikumar
    G. Ram Kumar
    Indian Journal of Pediatrics, 2021, 88 : 330 - 335
  • [22] Iron balance in thalassemia patients treated with deferiprone.
    Longo, F
    Fischer, R
    Engelhardt, R
    Nielsen, P
    Sacchetti, L
    Piga, A
    BLOOD, 1998, 92 (10) : 325A - 325A
  • [23] Efficacy and Safety of Combined Oral Chelation with Deferiprone and Deferasirox on Iron Overload in Transfusion Dependent Children with Thalassemia - A Prospective Observational Study
    DivakarJose, Rajeswari Rethinaswamy
    Delhikumar, C. G.
    Kumar, G. Ram
    INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (04): : 330 - 335
  • [24] Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox
    Economou, Marina
    Printza, Nikoletta
    Teli, Aikaterini
    Tzimouli, Vassiliki
    Tsatra, Ioanna
    Papachristou, Fotis
    Athanassiou-Metaxa, Miranda
    ACTA HAEMATOLOGICA, 2010, 123 (03) : 148 - 152
  • [25] Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major
    Olivieri, NF
    Brittenham, GM
    McLaren, CE
    Templeton, DM
    Cameron, RG
    McClelland, RA
    Burt, AD
    Fleming, KA
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (07): : 417 - 423
  • [26] Efficacy and tolerance of the oral iron chelator deferiprone in thalassemia: The Lebanese experience
    Taher, A
    Chamoun, FM
    Koussa, S
    Saad, MA
    Khoriaty, AI
    Neeman, R
    Mourad, FH
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 55 - 55
  • [27] Effect of oral iron chelation therapy with deferiprone (L1) on the psychosocial status of thalassaemia patients
    Zahed, L
    Mourad, FH
    Alameddine, R
    Aoun, S
    Koussa, S
    Taher, A
    HAEMATOLOGIA, 2002, 31 (04) : 333 - 339
  • [28] Efficient iron chelation resulting in improved myocardial performance with combined desferrioxamine and deferiprone in beta thalassemia major patients.
    Pathare, AV
    Daar, S
    Al Kindi, S
    Dennison, JD
    BLOOD, 2004, 104 (11) : 28B - 28B
  • [29] ORAL IRON CHELATION-THERAPY WITH DEFERIPRONE - MONITORING OF BIOCHEMICAL, DRUG AND IRON EXCRETION CHANGES
    KONTOGHIORGHES, GJ
    BARTLETT, AN
    SHEPPARD, L
    BARR, J
    NORTEY, P
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (01): : 65 - 69
  • [30] Dual Oral Iron Chelation in Thalassemia: Need for Robust Evidence
    Srinivasan Peyam
    Deepak Bansal
    Indian Journal of Pediatrics, 2021, 88 : 319 - 321
12345